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Objectives To characterise genotypes of Clostridium difficile strains isolated from asymptomatic individuals and
patients with diarrhea.
Methods Fecal specimens from 235 asymptomatic infants <12 months, 76 asymptomatic children
1–11 years and 132 adult patients with antibiotic-associated and non-antibiotic-associated diarrhea
obtained from Siriraj Hospital, Bangkok from October 1998 to April 1999 were examined for
C. difficile by cycloserine–cefoxitin–fructose agar culture. The presence of the C. difficile toxin A gene was
determined by specific PCR with the use of primers 5-(CCC AATAGA AGATTC AATATTAAG CTT)-
3 and 5-(GGA AGA AAAGAACTT CTG GCT CAC TCA GGT)-3. All C. difficile isolates were
subsequently genotyped by pulsed-field gel electrophoresis (PFGE).
Results The C. difficile strains were found in 28 (11.9%) asymptomatic infants, 16 (21.1%) asymptomatic
children and 33 (25%) adult patients. In total, 14 PFGE types and eight subtypes designated as types A, B, C,
D, E, F, G, H, I, J, K, L, M and N, and A1, A2, A3, A4, B1, B2, B3 and E1, respectively, were identified. Only
two isolates from infants and 18 isolates from adult patients were toxin A gene positive by PCR. Both isolates
of toxigenic C. difficile were from infants in the same ward and were PFGE type B. PFGE type A was the
predominant type among all toxigenic isolates (12 of 18 isolates) from adult patients. The other PFGE types
of toxigenic C. difficile found in adult patients were: type A1, one isolate; type B, four isolates; and type C, one
isolate. Types B2 and D were identified in 38.5% and 46.2%, respectively, of the toxin A gene-negative
isolates of C. difficile from infants.
Conclusions These results revealed the occurrence of three distinct clusters from different wards in Siriraj
Hospital. The toxigenic C. difficile of PFGE type A and related subtypes was a predominant infective clone in
adult patients, whereas non-toxigenic C. difficile types B2 and D were encountered in asymptomatic infants.
This information can be useful in epidemiologic investigations.
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INTRODUCTION
Clostridium difficile is a spore-forming anaerobic bacterium. It
has been recognised as a major cause of pseudomembranous
colitis, antibiotic-associated diarrhea, antibiotic-associated coli-
tis, and non-antibiotic-associated diarrhea [1–4]. This bacter-
ium produces at least two exotoxins: toxin A, an enterotoxin,
and toxin B, a potent cytotoxin. Both toxins are involved in the
diseases [1,5].
Because of the increasing incidence of nosocomial diarrhea
caused by C. difficile, there is a need for an effective procedure
for typing these bacteria in order to obtain information about
sources and routes of transmission. In a previous study, the
genotypic data obtained by the use of pulsed-field gel electro-
phoresis (PFGE) were shown to be particularly reliable in
establishing relatedness or identity among 11 C. difficile isolates
[6]. In the present study, all C. difficile strains isolated from fecal
specimens collected from asymptomatic infants, asymptomatic
children and adult patients with diarrhea were investigated for
the presence of the toxin A gene by using polymerase chain
reaction, in order to assess their occurrence and clinical sig-
nificance. We have extended PFGE analysis to a large sample of
both toxigenic and non-toxigenic C. difficile isolates in order to
search for correlations in genome characteristics.
MATERIALS AND METHODS
Patients and fecal specimens
In total, 446 fecal specimens were collected from three different
groups of patients at Siriraj Hospital, Bangkok, Thailand, from
October 1998 to April 1999. These included 235 asymptomatic
infants, 76 asymptomatic children and 132 adult patients who
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developed diarrhea during their hospital stays. Diarrhea was
defined as six or more unformed feces in 36 h. The adult
patients with diarrhea in this study could be divided into
two subgroups according to the physician’s diagnosis. The first
subgroup included 84 adult patients who developed diarrhea
during their hospital stays. The other subgroup of 48 adult
patients comprised the suspected cases of antibiotic-associated
diarrhea. There were two adult patients whose feces were
collected more than once, because of the development of
chronic diarrhea during their long hospital stays.
Culture
All fecal specimens were cultured for C. difficile by the use of a
selective medium, cycloserine–cefoxitin–fructose agar (CCFA,
Oxoid Ltd, Basingstoke, UK), and alcohol shock as previously
described [7].
Detection of the toxin A gene
The presence of the toxin A gene in all isolates of C. difficile was
determined by specific PCR with the use of the published
primers: 5-(CCC AAT AGA AGA TTC AAT ATT AAG
CTT)-3 and 5-(GGA AGA AAA GAA CTT CTG GCT
CAC TCA GGT)-3 [8]. The DNA samples were amplified
on a Perkin-Elmer Cetus Model 480 Thermocycler for 35
cycles at 95 8C for 95 s, ramping to 55 8C in 90 s; 55 8C for 30 s,
ramping to 60 8C in 30 s; and 60 8C for 120 s, ramping to
95 8C in 75 s. The toxin A-specific PCR product was 252 bp
long.
PFGE analysis
DNA extraction and PFGE of all C. difficile isolates were
performed as described previously [6]. Briefly, C. difficile cells
grown overnight in 20 mL of brain–heart infusion broth were
resuspended in TES (Tris-HCLþEDTAþNaCl) buffer to
achieve a McFarland turbidity of 3, and mixed with an equal
volume of 1.6% low melting agarose (Bio-Rad Laboratories,
Richmond, CA, USA) to make plugs for PFGE. The cells in the
plugs were treated with lysis solution and then with protease.
The DNA was digested overnight with SmaI (New England
Biolabs Inc,, Beverly, MA, USA). For PFGE, a CHEF DR II
system (Bio-Rad Laboratories, Richmond, CA, USA) was used
with switch times of 5 and 30 s for 24 h at 6 V/cm. The gels
were stained with ethidium bromide and photographed under
UV light. Chromosomal DNA of Saccharomyces cerevisiae (Bio-
Rad Laboratories) was used for molecular standard markers.
The isolates’ chromosomal fingerprints were compared by eye
and assigned to PFGE types and subtypes, according to the
published guideline [9]. Isolates with indistinguishable patterns
were considered to belong to the same PFGE type and were
designated by the same unique letter (e.g. A). Isolates with
patterns closely related (1–2-band difference) to that of an
already defined type were designated by the letter of that type
followed by a number (e.g. A1, A2).
Statistical analysis
Data were analysed using Epi Info Software version 6. Cate-
gorical variables were compared using chi-square test. A P-
value of <0.05 was considered significant.
RESULTS
C. difficile in three groups of patients
The C. difficile strains were found in 28 (11.9%) of 235 asymp-
tomatic infants, 16 (21.1%) of 76 asymptomatic children, and 33
(25%) of 132 adult patients, as shown in Table 1. The propor-
tions positive for C. difficile among the three groups of patients
were significantly different (P¼ 0.004). Thirteen of 84 (15.5%)
adult patients with diarrhea and 20 of 48 (41.7%) adult patients
with antibiotic-associated diarrhea had C. difficile in their stools
(P< 0.001). Toxigenic C. difficile were found in three (8.8%) of
20–40-year-old, four (9.5%) of 41–60-year-old and 11 (19.3%)
of >60-year-old patients. Although the highest numbers of
both C. difficile culture isolates (31.6%) and toxin A gene-
positive isolates (19.3%) were observed in diarrheal patients
at >60 years of age, there was no significant difference in
detection rates (P¼ 0.287).
Table1 Recovery of C. difficile from asymptomatic individuals and diarrheal patients
Patient group No. of persons
No. (%) of
C. difficile positive
No. (%) of toxin A gene
positive by PCR
Asymptomatic infants<12months 235 28 (11.9) 2 (0.9)
Asymptomatic children1^11years 76 16 (21.1) 0
Adults 132 33 (25.0) 18 (13.6)
With diarrhea 84 13 (15.5) 8 (9.5)
With antibiotic-associated diarrhea 48 20 (41.7) 10 (20.8)
Total 443 77 (17.4) 20 (4.5)
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Detection of the toxin A gene
Only two of 18 isolates from infants and 18 of 33 isolates from
adult patients were positive for toxin A gene by PCR. The toxin
A gene was found in eight C. difficile isolates of patients with
diarrhea (9.5%), while ten C. difficile isolates of patients with
suspected antibiotic-associated diarrhea had the toxin A gene
(20.8%) (Table 1).
PFGE analysis
In total, 14 PFGE types and eight subtypes designated as types
A, B, C, D, E, F, G, H, I, J, K, L, M and N, and A1, A2, A3, A4,
B1, B2, B3 and E1, respectively, were identified. The DNA
patterns obtained with PFGE analysis are shown in Figures 1
and 2. Both isolates of toxigenic C. difficile from infants in
the same ward were PFGE type B. PFGE type A was the
predominant type among all toxigenic isolates (12 of 18 isolates)
from adult patients. The other PFGE types of toxigenic C.
difficile found in adult patients were: type A1, one isolate; type B,
four isolates; and type C, one isolate. Among 14 non-toxigenic
C. difficile isolates from the symptomatic adults, nine PFGE
types were observed. Of these, types A3, B, B1, G and M were
each represented by two non-toxigenic strains, while B3, F, I
and N were each represented by only one strain. Types B2 and D
were identified in 38.5% and 46.2% of the toxin A gene-
negative isolates of C. difficile from infants. The greatest geno-
typic variety of non-toxigenic C. difficile was obtained in the
asymptomatic children group (13 PFGE types, 16 strains).
There were two adult patients who stayed in the hospital
longer than 2 months. They both developed chronic diarrhea
during that time. The genotype did not change among the
isolates obtained from the serial specimens from these patients.
Sequential isolates changed in subtype in only one patient after
2 months and 20 days (PFGE types A and A4). In another
patient, the PFGE type A strain persisted throughout the time
of the hospital stay (4 months and 20 days).
DISCUSSION
Five to 70 per cent of healthy infants have C. difficile in their
feces, but few of them develop the disease [1,2]. No one knows
why infants are protected, but there are a number of hypotheses,
including colostrum-containing substances which neutralise
toxins A and B [10], the immature nature of the intestinal
flora, and the lack of the toxin receptors in the intestine [5].
However, asymptomatic infants can spread this organism to
healthcare workers and the hospital environment, which could
be the possible mode of nosocomial transmission. In this study,
Figure 1 PFGE major patterns and subtypes of SmaI digests. The PFGE
types are shown in the lanes. Lanes1, 8 and15: lambda laddermolecular size
markers. Lanes 2^7 and 9^14: clinical isolates.
Figure 2 Fragment patterns of the C. difficile genome digested with SmaI
in strains isolated from diarrheal adult patients. The PFGE types are shown
above the lanes. Lanes1and10: lambda laddermolecular size marker. Lanes
2^9: clinical isolates.
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we found that 11.9% of infants harbored C. difficile. Two of these
infants carried toxigenic C. difficile and showed no signs or
symptoms of diarrheal disease.
The review by Bartlett [1] showed that toxigenic C. difficile
was implicated in 10–25% of cases of antibiotic-associated
diarrhea, and in 50–75% of cases of antibiotic-associated colitis.
More than 90% of those with pseudomembranous colitis
carried toxigenic C. difficile in their feces. A trend of increasing
prevalence of C. difficile has been reported in Europe and the
USA during the past 10 years.
In Thailand, there was no routine screening for C. difficile
infections in the clinical laboratory in the hospitals throughout
the country. The importance of C. difficile as a cause of diarrhea
appears to be under-recognised by our medical community,
whereas this study demonstrated an occurrence rate of 13.6%
for toxigenic C. difficile infections in hospitalised adult patients.
However, the difference in positivity rates of C. difficile stool
culture between adult patients with diarrhea and those with
antibiotic-associated diarrhea was statistically significant (13/84
versus 20/48, P< 0.001). It is now widely accepted that
toxigenic C. difficile is the most frequently encountered agent
of diarrhea among hospitalised patients. Routine laboratory
work-up protocols for fecal specimens should therefore be
designed for C. difficile culture and/or its toxin(s) detection.
In this study, the polymerase chain reaction was used for the
detection of the toxin A gene of C. difficile. Only toxin A
was determined, because both toxins (A and B) normally
act in a synergistic manner to cause C. difficile-associated disease.
It has been rarely reported that isolation of C. difficile from
patients could produce only toxin A or toxin B alone
[11,12].
C. difficile has become the most common agent of nosocomial
diarrhea in adults [13–15]. Typing methods could be important
in the epidemiologic investigation of nosocomial infections. In
this study, all 77 C. difficile strains isolated from study patients
were typed, but one isolate could not be typed by PFGE,
because of DNA fading. Our results confirmed that the PFGE
assay could generate a good discriminative capacity for inves-
tigating the relatedness of isolates recovered from different
patients. Two isolates from fecal specimens collected at different
periods of time from one adult patient were both PFGE type A.
The other two C. difficile isolates from one adult patient were
closely related PFGE types (type A and type A4).
In conclusion, the results showed that the occurrence of C.
difficile infections in adult patients was comparable to that
reported in developed countries. Routine detection of C.
difficile and/or its toxin(s) is therefore necessary in this region.
This study also confirms that the genotypic characteristics of C.
difficile isolates could be clearly identified by PFGE. It was found
that the major clones of both toxigenic and non-toxigenic
isolates of C. difficile obtained from asymptomatic individuals
and diarrheal patients were different. This may be very useful in
epidemiologic studies of the clonal distribution of C. difficile in
other settings.
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